Literature DB >> 31695246

Wilson Disease Presenting With Acute on Chronic Liver Failure: A Single-Center Experience of Outcome and Predictors of Mortality in 68 Patients.

Harshad Devarbhavi1, Vishnu V Reddy1, Rajvir Singh2.   

Abstract

BACKGROUND AND AIMS: Acute on chronic liver failure (ACLF) is an emerging entity whose unique pathogenesis, presentation, and outcome are different from those with decompensated cirrhosis. Patients with Wilson disease (WD) often present with ACLF. The outcome in this setting and predictors of mortality have not been well delineated. We describe the clinical features, laboratory characteristics, and prognostic factors in patients with WD with ACLF. We compared the outcome in those without criteria for ACLF. PATIENTS AND METHODS: We analyzed the admission characteristics of 68 patients with WD presenting with features of ACLF among a cohort of WD patients from 1997 to 2017. WD was diagnosed as per European association for the study of the liver (EASL)/Leipzig criteria and ACLF by the Asia-Pacific Association of Study of Liver and World Gastroenterology Organization consensus criteria. Factors associated with mortality were analyzed by univariate followed by multivariate analysis and receiver operating characteristic curve.
RESULTS: Of the 272 patients with WD, 68 fulfilled criteria for ACLF. The mean age was 14.4 years (Range 5-42 years). Males constituted 38/68 (56%). Acute viral or drug induced hepatitis as precipitating factors was seen in 11.7%. Forty-nine patients (49/67; 73%) died including 30/32 (93.8%) with encephalopathy and 45/62 (72.6%) with ascites. Prognostic factors on univariate analysis significant for mortality included encephalopathy, international normalized ratio, white blood cell count and model for end-stage liver disease (MELD) score. On multivariate analysis, only encephalopathy was significant with 82% accuracy in differentiating survivors versus non-survivors. Post mortem liver biopsy in 21 patients and explant biopsy in 2 patients showed features of cirrhosis in all.
CONCLUSIONS: WD with ACLF is associated with a high mortality Precipitating factors such as viral and drug-induced hepatitis was seen in 11.7% patients. Liver histology in patients subjected to biopsy showed cirrhosis in all. Only encephalopathy is a prognostic marker of non-survival with an accuracy of 82%.
© 2019 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACLF; ACLF, acute on chronic liver failure; CI, confidence interval; INR, International normalized ratio; OR, odds ratio; WD, Wilson disease; copper; encephalopathy; survival; wilson disease

Year:  2019        PMID: 31695246      PMCID: PMC6823726          DOI: 10.1016/j.jceh.2019.02.006

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  14 in total

1.  Penicillamine as a controversial treatment for Wilson's disease.

Authors:  P A LeWitt
Journal:  Mov Disord       Date:  1999-07       Impact factor: 10.338

2.  Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine.

Authors:  F Durand; J Bernuau; E Giostra; G Mentha; D Shouval; C Degott; J P Benhamou; D Valla
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

3.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).

Authors:  Shiv Kumar Sarin; Ashish Kumar; John A Almeida; Yogesh Kumar Chawla; Sheung Tat Fan; Hitendra Garg; H Janaka de Silva; Saeed Sadiq Hamid; Rajiv Jalan; Piyawat Komolmit; George K Lau; Qing Liu; Kaushal Madan; Rosmawati Mohamed; Qin Ning; Salimur Rahman; Archana Rastogi; Stephen M Riordan; Puja Sakhuja; Didier Samuel; Samir Shah; Barjesh Chander Sharma; Praveen Sharma; Yasuhiro Takikawa; Babu Ram Thapa; Chun-Tao Wai; Man-Fung Yuen
Journal:  Hepatol Int       Date:  2008-11-20       Impact factor: 6.047

4.  The liver biopsy diagnosis of Wilson's disease. Methods in pathology.

Authors:  J Ludwig; T P Moyer; J Rakela
Journal:  Am J Clin Pathol       Date:  1994-10       Impact factor: 2.493

5.  Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults.

Authors:  Yu Shi; Ying Yang; Yaoren Hu; Wei Wu; Qiao Yang; Min Zheng; Shun Zhang; Zhaojun Xu; Yihua Wu; Huadong Yan; Zhi Chen
Journal:  Hepatology       Date:  2015-04-25       Impact factor: 17.425

6.  Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation.

Authors:  Radan Bruha; Zdenek Marecek; Lenka Pospisilova; Sona Nevsimalova; Libor Vitek; Pavel Martasek; Jiri Nevoral; Jaromir Petrtyl; Petr Urbanek; Alena Jiraskova; Peter Ferenci
Journal:  Liver Int       Date:  2010-10-20       Impact factor: 5.828

7.  Wilson's disease: clinical presentation and use of prognostic index.

Authors:  H Nazer; R J Ede; A P Mowat; R Williams
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

8.  Wilson disease mutation pattern with genotype-phenotype correlations from Western India: confirmation of p.C271* as a common Indian mutation and identification of 14 novel mutations.

Authors:  Annu Aggarwal; Gursimran Chandhok; Theodor Todorov; Saloni Parekh; Sharada Tilve; Andree Zibert; Mohit Bhatt; Hartmut H-J Schmidt
Journal:  Ann Hum Genet       Date:  2013-04-02       Impact factor: 1.670

9.  Toward an improved definition of acute-on-chronic liver failure.

Authors:  Rajiv Jalan; Cihan Yurdaydin; Jasmohan S Bajaj; Subrat K Acharya; Vicente Arroyo; Han-Chieh Lin; Pere Gines; W Ray Kim; Patrick S Kamath
Journal:  Gastroenterology       Date:  2014-05-20       Impact factor: 22.682

10.  Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients.

Authors:  Tawhida Y Abdel Ghaffar; Solaf M Elsayed; Suzan Elnaghy; Ahmed Shadeed; Ezzat S Elsobky; Hartmut Schmidt
Journal:  BMC Pediatr       Date:  2011-06-17       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.